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Orofacial pain is often diﬃcult to diagnose and treat.  However,  there have been few reports on the 
clinical observation of dental patients with orofacial pain.  We retrospectively investigated the charac-
teristics of 221 dental patients who had suﬀered from persistent orofacial pain.  Data were collected 
from the outpatient medical records in our clinic over the past 12 years.  More than half of the 
patients (53.8ｵ) had suﬀered with pain for more than 6 months from pain onset until the ﬁrst visit to 
our clinic.  The main diagnoses were neuropathic pain (30.3ｵ),  myofascial pain (23.5ｵ),  psychogenic 
pain (20.4ｵ),  odontogenic toothache (17.2ｵ),  and others (7.7ｵ) such as temporomandibular disorders 
and glossitis.  The treatments included pharmacotherapy,  splint therapy,  and others such as nerve 
block,  dental treatment,  physiotherapy,  and/or psychotherapy.  Excluding the patients (52 of 221 ini-
tially enrolled patients) with unknown responses to treatment,  65.7ｵ showed remission or a signiﬁcant 
improvement in pain in response to treatment.  Although only a small group of patients had odonto-
genic toothache,  the rate of improvement was highest for this disorder.  In conclusion,  early consulta-
tion with a dentist is useful to prevent chronicity of odontogenic pain and to make a diﬀerential diag-
nosis in patients with orofacial pain.
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ome dental patients have persistent pain in the 
oral and maxillofacial region even after provi-
sion of common treatments by a general dental practi-
tioner.  Recently,  such persistent pain has been called 
orofacial pain,  to distinguish it from common dental 
diseases with more easily recognized diagnostic crite-
ria.  Orofacial pain is usually accompanied by a com-
plex pathological condition [1],  and often includes 
referred pain from a distant tooth or area [2].  
Therefore,  the diagnosis of orofacial pain is generally 
thought to be diﬃcult [1-3].  Because the orofacial 
region has biological,  emotional,  and psychological 
importance,  many factors can be involved in orofacial 
pain [1].  Furthermore,  many patients with orofacial 
pain have a long history of the condition,  and such 
long duration of pain sometimes leads to psychological 
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disorders [4,  5],  which in turn aﬀect the degree and 
character of the pain [4,  6,  7],  making the condition 
even more complex and persistent.  Therefore,  it is 
necessary to diagnose and treat orofacial pain early in 
order to avoid an increase in complexity and a shift to 
chronic pain.  However,  due to the dearth of clinical 
reports on dental patients with orofacial pain,  the 
clinical information on orofacial pain remains insuﬃ-
cient.
　 We have diagnosed and treated many patients with 
orofacial pain at our clinic,  the Department of Dental 
Anesthesiology of Okayama University Hospital.  We 
therefore performed a clinical review of dental 
patients with orofacial pain who visited our clinic over 
a period of 12 years.
Materials and Methods
　 The present study was approved by the Ethics 
Committee of Okayama University Graduate School of 
Medicine,  Dentistry and Pharmaceutical Sciences 
(No.  672).
　 We retrospectively investigated the characteristics 
of dental patients who had suﬀered from orofacial 
pain.  Data were collected from the outpatient medical 
records in our Clinic of Dental Anesthesiology for the 
years of January 2001 to December 2012.  We extracted 
the patientsʼ diagnoses,  gender,  age,  location of pain,  
duration of pain,  treatments,  and responses to treat-
ments.
　 The diagnoses were made based on the character-
istics of pain,  X-ray ﬁndings,  physiological tests,  a 
drug challenge test,  and psychological tests.  In some 
diﬃcult cases,  the patients were diagnosed with an 
interdisciplinary approach.  Patients were classiﬁed 
using criteria for orofacial pain modiﬁed from the 
guidelines of the Japanese Society of Orofacial Pain.  
The responses to the treatments were classiﬁed into 4 
levels: remission,  signiﬁcant improvement,  partial 
response,  and no response,  based on the pain-assess-
ment documentation from the medical records.
Results
　 Patients. Three hundred and twelve patients 
with orofacial pain visited our outpatient department.  
Of these patients,  221 with orofacial pain were inves-
tigated,  and 91 patients with peripheral nerve damage,  
dysgeusia,  or an unidentiﬁed complaint were excluded 
from the present study.  Two hundred and eleven 
(95.5ｵ) of the patients were introduced to our clinic 
by general practitioners in local dental clinics or other 
specialists in our hospital,  such as oral surgeons and 
periodontologists.
　 Diagnoses. The diagnoses are shown in Table 
1.  The patients with non-odontogenic pain comprised 
81.9ｵ of the total subject group,  and included 
patients with neuropathic pain,  myofascial pain,  psy-
chogenic pain,  and other types of pain such as tem-
poromandibular disorders and glossitis,  while the 
patients with odontogenic toothache comprised 17.2ｵ 
of the total.  Two patients could not be given a deﬁnite 
diagnosis of pain.  In the present study,  Neuropathic 
pain was the most in (patients with) non-odontogenic 
pain.
　 Gender and age. The patients included 52 
males (23.5ｵ) and 169 females (76.5ｵ),  aged between 
16 and 89 years old,  with a mean ± SD age of 56.6
±16.7 years.  The prevalence of pain was more than 
3 times as high in females compared to males,  and 
every diagnosis was more prevalent in females than 
males (Fig.  1).  This tendency was particularly marked 
for myofascial pain.  The ages were 62.7±15.6,  50.7
±16.9,  60.7±15.0,  49.4±16.4,  and 53.9±15.1 
years in patients with neuropathic pain,  myofascial 
pain,  psychogenic pain,  odontogenic toothache,  and 
others,  respectively (Fig.  2).
　 Location of pain. Table 2 shows the locations 
of pain.  They included the jaws,  face,  tongue,  tem-
poromandibular joint,  and others locations including 
the neck,  head,  lips,  mouth ﬂoor,  and pharynx.  Pain 
occurred in the jaws at the highest rate for every 
diagnosis (Table 2).  Neuropathic and psychogenic pain 
were also found at a relatively high rate in the face 
and tongue,  respectively.  As for the location of pain 
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Table 1　 Classiﬁcation of orofacial pain
Diagnosis Number of patients (rate)
Non-odontogenic pain 181 (81.9%)
　Neuropathic pain 67 (30.3%)
　Myofascial pain 52 (23.5%)
　Psychogenic pain 45 (20.4%)
　Others 17 (7.7%)
Odontogenic toothache 38 (17.2%)
No diagnosis 2 (0.9%)
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Table 2　 Location of orofacial pain (number of patients and rate)
Total Neuropathicpain
Myofascial
pain
Psychogenic
pain
Odontogenic
toothache
Others or no
diagnosis
Jaws 137 (62.0%) 32 (47.8%) 42 (80.8%) 24 (53.3%) 36 (94.7%) 3 (15.8%)
Face  43 (19.5%) 28 (41.8%)  7 (13.5%) 3 (6.7%) 2 (5.3%) 3 (15.8%)
Tongue  24 (10.9%) 3 (4.5%) 0 17 (37.8%) 0 4 (21.1%)
TMJ  8 (3.6%) 1 (1.5%) 1 (1.9%) 0 0 6 (31.6%)
Others  9 (4.1%) 3 (4.5%) 2 (3.8%) 1 (2.2%) 0 3 (15.8%)
TMJ, Temporomandibular joint.
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Fig. 1　 The number of men and women with each type of orofacial pain.
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Fig. 2　 The age of patients with each type of orofacial pain.
in the jaws,  the number of patients with pain in the 
posterior region was greater than that of patients with 
pain in the anterior region (Table 3).
　 Duration of pain. The durations of pain from 
onset until the ﬁrst visit to our clinic were less than 3 
months in 70 patients (31.7ｵ),  between 3 and 6 
months in 25 patients (11.3ｵ),  between 6 months and 
2 years in 48 patients (21.7ｵ),  and more than 2 years 
in 71 patients (32.1ｵ).  The duration was unknown in 
7 patients.  In those with neuropathic pain,  the dura-
tion was less than 3 months,  while those with myofas-
cial pain had a duration of more than 2 years (Fig.  3).
　 Treatments for pain. Treatments for the pain 
included pharmacotherapy in 151 patients (68.3ｵ),  
splint therapy in 55 patients (24.9ｵ),  and/or other 
treatments such as nerve block,  dental treatment,  
physiotherapy,  and/or psychotherapy such as coun-
seling.  The drugs administered for pharmacotherapy 
are shown in Table 4.  Patients who were diagnosed 
with neuropathic pain were administered drugs such as 
carbamazepine and pregabalin.  Half of the patients 
with neuropathic pain were diagnosed with trigeminal 
neuralgia,  and were introduced to neurosurgeons after 
pain relief with medication.  Patients with psychogenic 
pain were mainly administered ethyl loﬂazepate,  
sulpiride,  and/or amitriptyline hydrochloride.  The 
patients with myofascial pain were mainly adminis-
tered drugs such as ethyl loﬂazepate and/or tizanidine 
hydrochloride and underwent splint therapy.  Medication 
in conjunction with cognitive behavioral therapy or 
splint therapy was useful for the patients with a long 
history of pain.  The patients with odontogenic tooth-
272 Acta Med.  Okayama　Vol.  68,  No.  5Tomoyasu et al.
Table 4　 Drugs administered for orofacial pain (number of patients)
Classiﬁcation Drugs (patients)
Benzodiazepines Ethyl loﬂazepate (74)
Others (6)
Anticonvulsant agents Carbamazepine (45)
Clonazepam (8)
Others (4)
Benzamide Sulpiride (16)
Muscle relaxants Tizanidene hydrochloride (18)
Others (5)
Tricyclic antidepressant Amitriptyline hydrochloride (7)
Others NSAIDs (11)
Pregabalin (5)
Others (35)
Table 3　 Location of orofacial pain in the jaw region (number of patients and rate)
Total Anterior Posterior Both
Upper jaw 58 (42.3%) 13 (9.5%) 45 (32.8%) 0
Lower jaw 53 (38.7%) 5 (3.6%) 48 (35.0%) 0
Both jaws 26 (19.0%) 2 (1.5%) 13 (9.5%) 11 (8.0%)
Others or no diagnosis
Odontogenic toothache
Psychogenic pain
Myofascial pain
Neuropathic pain
Total
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Fig. 3　 The duration of each type of orofacial pain.
ache underwent dental treatment and/or splint therapy 
as needed.
　 Responses to treatments. The responses of 
patients to the treatments were evaluated,  excluding 
the patients (52 patients) whose responses could not be 
evaluated due to discontinuing visitation.  Fig.  4 
shows the response rates for the 169 patients.  The 
rate of remission or signiﬁcant improvement in each 
diagnosis was 67.3ｵ for neuropathic pain,  59.6ｵ for 
myofascial pain,  60.5ｵ for psychogenic pain,  and 
85.2ｵ for odontogenic toothache.
Discussion
　 There have been few reports on the clinical obser-
vation of dental patients with orofacial pain.  Thus,  the 
present study shows the clinically signiﬁcant ﬁnding of 
orofacial pain in dental patients.  In the present study,  
neuropathic pain was the most in patients with non-
odontogenic pain.  Among the patients with neuro-
pathic pain,  82.1ｵ had trigeminal neuralgia in the 
present study.  In agreement with our results,  another 
investigation has revealed that trigeminal neuralgia 
showed the highest rate (around 30ｵ) in patients with 
facial pain [8].
　 Recent research has shown there are gender diﬀer-
ences in pain perception [9-11].  Our study also 
indicates that orofacial pain is more frequent in 
females than in males.  Lipton et al.  [9] determined 
that the prevalence rates among females were consis-
tently higher than those in males for all types of oro-
facial pain.  Regarding chronic pain in other regions,  
female patients have also been reported to show a 
higher prevalence than males [12,  13].
　 Some reports have described orofacial [11] and 
chronic [14] pain as being most frequently observed 
within the age bracket of 45-64 years,  and have 
shown that the prevalence of all chronic pain condi-
tions increased with age [13].  In the present study,  
the patients with neuropathic or psychogenic pain were 
older than those with myofascial pain or odontogenic 
toothache.  In agreement with our results,  trigeminal 
neuralgia was reported to occur frequently in the age 
group between 50 and 70 years [15].  The ﬁndings in 
the present study suggest that neuropathic and psy-
chogenic pain are likely to occur in relatively older 
people,  while myofascial pain and odontogenic tooth-
ache tend to occur in middle-aged people.
　 Our results showed that orofacial pain most fre-
quently occurred in the jaw region.  On the other hand,  
the face was the most frequent location in patients with 
neuropathic pain (65.1ｵ),  and the tongue was the most 
frequent location in patients with psychogenic pain 
(70.8ｵ).  These ﬁndings should assist in the diﬀeren-
tial diagnosis of orofacial pain.
　 Orofacial pain often lasts over 6 months and it can 
lead to chronicity labeled chronic pain [5,  16,  17].  
Regarding the duration of pain in the present study,  
more than half of the investigated patients had suf-
fered for over 6 months before visiting our clinic.  On 
diﬀerential diagnosis,  chronic pain was found in 
71.2ｵ,  57.9ｵ,  51.1ｵ,  and 43.2ｵ of patients with 
myofascial pain,  odontogenic toothache,  psychogenic 
pain,  and neuropathic pain,  respectively.  Some 
reports [3,  18] showed that the duration was variable 
and may span several years.  Another report [19] 
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Fig. 4　 The treatment responses for each type of orofacial pain.
estimated that the majority of individuals with orofa-
cial pain experience an initial pain episode lasting 
more than 3 years.  The duration of toothache is gen-
erally short and less than 6 months [11] or one year 
[10] due to the easy diagnosis.  In our study,  the 
duration of neuropathic pain was the shortest,  less 
than 3 months.  In contrast,  myofascial pain had a 
duration of more than 2 years in our study,  which was 
the longest among the types of pain studied.  This may 
be have been because myofascial pain was more diﬃ-
cult for the general practitioners or other specialists 
to diﬀerentiate from common dental diseases than 
neuropathic pain.
　 Pharmacotherapy is the mainstay of treatment for 
orofacial pain,  and the choice of medication depends 
on the type of pain diagnosed.  Trigeminal neuralgia 
usually responds to carbamazepine [4,  20],  while 
several recent studies have reported that anticonvul-
sants (pregabalin) and antidepressants (duloxerine) 
are helpful for neuropathic orofacial pain [20-23].  
However,  based on our experience,  SNRIs are not 
particularly eﬀective for orofacial pain.  These results 
suggest that there may be some diﬀerences between 
orofacial and other types of body pain.  Amitriptyline 
hydrochloride,  a tricyclic antidepressant,  has been 
reported to be eﬀective for neuropathic [4,  22],  
myofascial [4],  and psychogenic [24] pain.  Low dose 
amitriptyline might be useful for neuropathic and 
psychogenic orofacial pain even though some patients 
complain of intraoral discomfort.  Benzodiazepines are 
useful in the treatment of anxiety disorder including 
panic attacks,  although,  in our setting,  ethyl loﬂazepate 
was the most prescribed drug in patients with myofas-
cial and psychogenic pain.  Although issues of toler-
ance and dependence often limit the long-term use of 
benzodiazepines,  we encountered few cases requiring 
limitation in our series.
　 In addition to pharmacotherapy,  we have used 
splint therapy to treat patients with myofascial pain,  
since this treatment is noninvasive and has been 
reported to be eﬀective [25].  In addition,  we have 
employed psychotherapy for psychogenic pain,  which 
is important for chronic pain [26,  27].
　 Regarding the eﬀect of our treatments,  111 
patients (65.7ｵ of 169 patients) showed remission or 
signiﬁcant improvement in response to therapy,  
excluding the patients (52 patients) with an unknown 
response to treatment.  This means that about two-
thirds of those patients with orofacial pain in whom we 
could conﬁrm the course after treatment were able to 
achieve remission or signiﬁcant improvement.  In par-
ticular,  in odontogenic toothache,  the rate of remis-
sion or signiﬁcant improvement was 85.2ｵ,  which was 
the highest rate.  Odontogenic toothache can be 
relieved as soon as the cause of the dental disease is 
identiﬁed.  If the patients can be accurately diagnosed 
by general practitioners or other specialists,  they will 
not have to suﬀer from pain for a very long time.  This 
result indicates that odontogenic toothache is one of 
the most important entities to treat easily.  General 
practitioners should thus be attentive to the possibil-
ity of odontogenic toothache in patients with orofacial 
pain.
　 There were some limitations in the present study.  
First,  the number of patients with each diagnosis was 
small,  so we did not statistically analyze the data for 
each diagnosis.  This was because the overall number 
of patients with orofacial pain was itself limited,  even 
though the study was conducted at a university hospi-
tal.  Next,  temporomandibular pain caused by tem-
poromandibular disorder has been known to frequently 
occur as orofacial pain [28].  However,  in our hospi-
tal,  such patients are referred to a special clinic for 
temporomandibular disorder,  and thus patients with 
temporomandibular pain may have been excluded from 
our study group.  In addition,  the assessment of 
responses to our treatments was performed based on 
descriptive documentation of pain assessment from 
medical records.  There are several methods to evalu-
ate the measurement of the quality of pain management 
for improvement,  based on some factors,  including 
pain intensity measures,  impact of pain on function,  
patient satisfaction,  patient beliefs,  documentation of 
pain assessments,  and range and appropriateness of 
treatment [29].  Recently,  the use of a core set of 
indicators has been recommended--namely,  pain inten-
sity,  treatment,  degree of facilitation of function and 
quality of life,  and adequacy of information about pain 
management,  has been recommended.
　 In conclusion,  we retrospectively investigated the 
patients with orofacial pain who were seen in our 
department over a period of 12 years.  The majority of 
patients had suﬀered from pain lasting for more than 
6 months.  Despite the small rate of odontogenic tooth-
ache (17.2ｵ) in all patients,  85.2ｵ of the patients 
with odontogenic toothache recovered after dental 
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treatment.  Early consultation with a dentist is useful 
to prevent the chronicity of odontogenic pain and to 
make a diﬀerential diagnosis in patients with orofacial 
pain.
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